These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37209374)

  • 1. Post-COVID-19 Pulmonary Fibrosis: Facts-Challenges and Futures: A Narrative Review.
    Duong-Quy S; Vo-Pham-Minh T; Tran-Xuan Q; Huynh-Anh T; Vo-Van T; Vu-Tran-Thien Q; Nguyen-Nhu V
    Pulm Ther; 2023 Sep; 9(3):295-307. PubMed ID: 37209374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation between serum levels of laminin, type IV collagen, type III procollagen N-terminal peptide and hyaluronic acid with the progression of post-COVID-19 pulmonary fibrosis.
    Yu D; Yin G; Lei J; Gong Y; Zheng L; He D; Lei L; Sun L
    Front Cell Dev Biol; 2024; 12():1382244. PubMed ID: 38979035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary fibrosis in patients with COVID-19: A review].
    Chuchalin AG
    Ter Arkh; 2022 Dec; 94(11):1333-1339. PubMed ID: 37167174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and Safety of Pirfenidone and Nintedanib for Pulmonary Fibrosis in COVID-19-Induced Severe Pneumonia: An Interventional Study.
    Choudhary R; Kumar A; Ali O; Pervez A
    Cureus; 2022 Sep; 14(9):e29435. PubMed ID: 36299940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-intensive care syndrome and pulmonary fibrosis in patients surviving ARDS-pneumonia of COVID-19 and non-COVID-19 etiologies.
    Sturgill JL; Mayer KP; Kalema AG; Dave K; Mora S; Kalantar A; Carter DJ; Montgomery-Yates AA; Morris PE
    Sci Rep; 2023 Apr; 13(1):6554. PubMed ID: 37085548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
    Zheng Z; Peng F; Zhou Y
    Chin Med J Pulm Crit Care Med; 2023 Jun; 1(2):77-83. PubMed ID: 37388822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary fibrosis in patients with COVID-19: A retrospective study.
    Li F; Deng J; Song Y; Wu C; Yu B; Wang G; Li J; Zhong Y; Liang F
    Front Cell Infect Microbiol; 2022; 12():1013526. PubMed ID: 36619759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosis.
    Bingham GC; Muehling LM; Li C; Huang Y; Ma SF; Abebayehu D; Noth I; Sun J; Woodfolk JA; Barker TH; Bonham CA
    Front Immunol; 2023; 14():1308594. PubMed ID: 38292490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients.
    Giacomelli C; Piccarducci R; Marchetti L; Romei C; Martini C
    Biochem Pharmacol; 2021 Nov; 193():114812. PubMed ID: 34687672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term pulmonary sequelae in adolescents post-SARS-CoV-2 infection.
    Palacios S; Krivchenia K; Eisner M; Young B; Ramilo O; Mejias A; Lee S; Kopp BT
    Pediatr Pulmonol; 2022 Oct; 57(10):2455-2463. PubMed ID: 35775163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19.
    Kooistra EJ; Dahm K; van Herwaarden AE; Gerretsen J; Nuesch Germano M; Mauer K; Smeets RL; van der Velde S; van den Berg MJW; van der Hoeven JG; Aschenbrenner AC; Schultze JL; Ulas T; Kox M; Pickkers P
    Respir Res; 2023 Aug; 24(1):196. PubMed ID: 37559053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Cryptococcosis and Pulmonary Fibrosis: A Complication of COVID-19 Pneumonia.
    Isaac S; Pasha MA; Isaac S; Kyei-Nimako E; Lal A
    Cureus; 2023 Mar; 15(3):e35660. PubMed ID: 37009361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of Life.
    Nopp S; Moik F; Klok FA; Gattinger D; Petrovic M; Vonbank K; Koczulla AR; Ay C; Zwick RH
    Respiration; 2022; 101(6):593-601. PubMed ID: 35203084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary manifestations in long COVID].
    Sommer N; Schmeck B
    Inn Med (Heidelb); 2022 Aug; 63(8):819-829. PubMed ID: 35925073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis.
    Lee JH; Yim JJ; Park J
    Respir Res; 2022 Sep; 23(1):233. PubMed ID: 36068582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Sequelae of Coronavirus Disease 2019.
    Whiteson JH
    Phys Med Rehabil Clin N Am; 2023 Aug; 34(3):573-584. PubMed ID: 37419533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Prognostically Significant Factors in COVID-19-Associated Pulmonary Fibrosis after Adaptive Lung Ventilation.
    Mirsaliyev M; Kashikova K; Zholdybayeva A; Myrzakhmetova B; Isbassarova A; Petrova N; Kozhamberdiyeva D
    Med J Islam Repub Iran; 2023; 37():118. PubMed ID: 38145181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application.
    Zhao Y; Yan Z; Liu Y; Zhang Y; Shi J; Li J; Ji F
    Stem Cell Res Ther; 2021 Aug; 12(1):470. PubMed ID: 34420515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.